GPT-Rosalind Is Not a Clinical Trial Tool. It Is a Clinical Trial Problem.
Clinical operations leaders are not prepared for the downstream impact of GPT-Rosalind. Explore the hidden trial infrastructure risks of...
Clinical operations leaders are not prepared for the downstream impact of GPT-Rosalind. Explore the hidden trial infrastructure risks of...
Compare QMENTA vs icometrix neuroimaging platforms: clinical trial infrastructure vs point-of-care diagnostics. Choose the right solution for MS...
Multi-site neuroimaging trials face protocol drift, QC bottlenecks, and audit gaps. A 2026 look at operational realities and what actually impacts...
QMENTA vs. Flywheel.io: Compare FDA-cleared CNS clinical AI vs. enterprise R&D infrastructure. See which medical imaging platform fits your trial.
QMENTA vs Medidata Rave Imaging: compare AI biomarkers, central review, imaging EDC, and which platform fits your clinical trial.
QMENTA Co-Founder Paulo Rodrigues shares observations from LSX World Congress Europe 2026: why biotech's bottleneck is execution, not science, and...
Every year, we bring in an independent third party to try to break into our platform. And this year, we are publishing the results — not because...
Veteran CRO executive and investor brings more than 30 years of clinical research leadership and deep pharma networks to the Barcelona-based medical...
This post reviews QMENTA's 2025 progress in clinical imaging infrastructure, including enterprise security compliance, regulatory validation with...